Background: Both exercise training and diet are recommended to prevent and control hypertension and overweight/ obesity. Purpose: The purpose of this study was to determine the effectiveness of different 16-week aerobic exercise programmes with hypocaloric diet on blood pressure, body composition, cardiorespiratory fitness and pharmacological treatment. Methods: Overweight/obese, sedentary participants (n ¼ 175, aged 54.0 AE 8.2 years) with hypertension were randomly assigned into an attention control group (physical activity recommendations) or one of three supervised exercise groups (2 days/week: high-volume with 45 minutes of moderate-intensity continuous training (MICT), high-volume and highintensity interval training (HIIT), alternating high and moderate intensities, and low-volume HIIT (20 minutes)). All variables were assessed pre-and post-intervention. All participants received the same hypocaloric diet. Results: Following the intervention, there was a significant reduction in blood pressure and body mass in all groups with no between-group differences for blood pressure. However, body mass was significantly less reduced in the attention control group compared with all exercise groups (attention control -6.6%, high-volume MICT -8.3%, high-volume HIIT -9.7%, low-volume HIIT -6.9%). HIIT groups had significantly higher cardiorespiratory fitness than high-volume MICT, but there were no significant between-HIIT differences (attention control 16.4%, high-volume MICT 23.6%, high-volume HIIT 36.7%, low-volume HIIT 30.5%). Medication was removed in 7.6% and reduced in 37.7% of the participants. Conclusions: The combination of hypocaloric diet with supervised aerobic exercise 2 days/week offers an optimal nonpharmacological tool in the management of blood pressure, cardiorespiratory fitness and body composition in overweight/obese and sedentary individuals with hypertension. High-volume HIIT seems to be better for reducing body mass compared with low-volume HIIT. The exercise-induced improvement in cardiorespiratory fitness is intensity dependent with low-volume HIIT as a time-efficient method in this population. ClinicalTrials.gov Registration: NCT02283047.
Introduction
Due to the recent changes in both eating habits and lifestyles (i.e. the abandonment of traditional dietary patterns and culinary techniques, increased sedentary time, and decreased volume and intensity of physical activity, which results in an imbalance in the energy balance), primary hypertension, overweight/obesity, and being sedentary often coexist in the same person. 1, 2 Obesity has been considered the driving force of this response culminating in a significant increase in direct and indirect healthcare costs. 3 It is, therefore, important to develop cost-effective strategies for the treatment of obesity in order to reduce the prevalence of obesity-related hypertension. 2, 4 The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) recommend appropriate lifestyle changes for the prevention and treatment of hypertension, alongside the use of drug therapy in individuals at high risk. 5 One benefit of losing body mass is the concomitant reduction in blood pressure (BP), 2, 3, 5 especially in individuals taking antihypertensive medication. 6 Although individual BP responses to a reduced body mass are variable depending on 'fat-sensitive' or 'fat-resistant' BP, 1 it has been demonstrated that combining exercise and diet may be the most effective treatment for reducing body mass. Consequently, the combination appears to be a logical step in facilitating a substantial improvement in cardiometabolic health, including hypertension. 2, 5 During the past two decades, several studies have shown the effectiveness of adherence to the dietary approaches to stop hypertension (DASH) dietary pattern. 4, 7, 8 In a population with hypertension, the combination of the DASH diet with aerobic exercise has resulted in a greater reduction in BP and improved cardiovascular biomarkers than the DASH diet alone. 9 Exercise guidelines recommend that both moderateintensity and high-intensity aerobic training should be used to treat and reduce hypertension. 5 However, there is currently no agreement with respect to the optimal frequency, intensity, time, and type (FITT principle) of exercise prescription. 10 Previously, aerobic high-intensity interval training (HIIT) produced a significant improvement in BP and cardiorespiratory fitness (CRF) compared with moderate-intensity continuous training (MICT). [11] [12] [13] In addition, a dose-response curve for physical activity volume and intensity has previously been reported; this is especially important for sedentary individuals and those with a moderate level of physical condition, 14 suggesting that 'some is good but more is better'. There is also evidence to support the use of low-volume HIIT (i.e. 10 minutes of high-intensity effort) versus high-volume HIIT as a potent and time-efficient training method suggesting 'less is more'. 15 Currently, no research has determined the effects of different exercise intensities and volumes combined with a hypocaloric diet intervention in overweight/ obese, sedentary adults diagnosed with hypertension. Therefore, the aim of this study was to determine changes in BP, body composition, CRF and pharmacological treatment following three different (highvolume MICT, high-volume HIIT, low-volume HIIT) 16-week aerobic exercise programmes performed twice a week, all combined with a hypocaloric diet.
Methods

Study design
The EXERDIET-HTA study is a multi-arm parallel, randomised, single-blind controlled experimental trial comparing the effects of different 16-week aerobic exercise programmes (performed 2 days/week) combined with a dietary intervention in sedentary, overweight/ obese individuals with hypertension (www.clinicaltrials.gov, number NCT02283047). The study protocol was approved by the ethics committee of the University of the Basque Country (UPV/EHU, CEISH/279/2014) and clinical investigation of Araba University Hospital (2015-030), and all participants provided written informed consent before any data collection. Medical staff were blinded to the participant randomisation process. The design, selection criteria and procedures for the EXERDIET-HTA study have been detailed previously. 16 
Participants
One hundred and seventy-five non-Hispanic white participants (n ¼ 120 men and n ¼ 55 women) were enrolled in the study from September 2013 to June 2016 in Vitoria-Gasteiz (Basque Country, Spain). Figure 1 presents a flow diagram of the study process. All participants were classified as overweight (body mass index (BMI) > 25 kg/m 2 ) or obese (BMI > 30 kg/m 2 ) 3 and diagnosed with stage 1 or 2 hypertension, defined as a systolic blood pressure (SBP) of 140-179 mmHg and/or a diastolic blood pressure (DBP) of 90-109 mmHg and/ or under antihypertensive pharmacological treatment. 5 Physical activity behaviour was determined by the international physical activity questionnaire (IPAQ), and only participants who did not comply with the 'Global recommendations on physical activity for health' 17 by the World Health Organization were selected.
Measurements
The measurements for the study were taken pre (T0) and post (T1) each 16-week intervention period.
Blood pressure. Ambulatory blood pressure monitoring (ABPM) was conducted over a 24-hour period using an oscillometric ABPM 6100 (Welch Allyn, New York City, NY, USA) device to evaluate BP in line with the guidelines set by the ESH/ESC. 5 Blood pressure (ABPM) values are displayed as the mean of the day.
Cardiorespiratory fitness. A cardiopulmonary exercise test was used to determine peak oxygen uptake ( _ VO 2peak ) and ventilatory thresholds (VT). The cardiopulmonary exercise test was performed on an electronically braked Lode Excalibur Sport Cycle Ergometer (Groningen, The Netherlands). The test protocol started at approximately 70 rpm and 40 W, with gradual increments of 10 W every minute applied until volitional exhaustion occurred. Continuous electrocardiogram monitoring was conducted throughout each test. Expired gas analysis was assessed using a commercially available metabolic cart (Ergo CardMedi-soft S.S, Belgium; Ref. USM001 V1.0). Achievement of _ VO 2peak criteria has previously been defined. 18 Ventilatory thresholds (i.e. VT1 and VT2) were assessed by standardised methods using the ventilatory equivalents. 18 After completion of the test, participants remained stationary on the bike for 5 minutes recovery with electrocardiogram and BP monitoring throughout. The identification of the two VT determined the three different exercise intensity domains, or ranges for the exercise intervention design (i.e. R1, light to moderate; R2, moderate to high; R3, high to severe).
18
Dietary assessment. Habitual food consumption and nutrient intake were evaluated using three questionnaires: dietary history, food frequency questionnaire and two face-to-face non-consecutive 24-hour recalls. Trained dieticians conducted the necessary correction for within-subject variability in nutrient intake. 19 All nutritional data were calibrated in the Easy Diet computer program. Resting energy expenditure was calculated by the Mifflin St Jeor equation, which has previously been deemed the most appropriate for individuals who are overweight or obese. 20 Medication. Prescribed medications were recorded and classified into the groups: angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor 
Intervention
All participants underwent a hypocaloric diet. Following baseline data collection, participants were randomly allocated to one of the four intervention groups: the attention control (AC) group, or the three supervised exercise groups (high-volume MICT, highvolume HIIT, or low-volume HIIT). Each group was stratified by gender, SBP, BMI and age. All participants were asked to continue with their normal physical activity patterns outside of the study protocol. However, in addition to treatment for the hypocaloric diet, the AC group received the standard guidelines for physical activity recommendations in order to comply with ethical procedures regarding health.
5
Intervention procedures. All exercise groups trained for two non-consecutive days per week under the supervision of exercise specialists. All sessions started and finished with BP monitoring, and training intensity was dictated by individual heart rate (HR) responses (Polar Electro, Kempele, Finland) and the rate of perceived exertion (Borg's 6-20 point). Each session included a 5-10-minute warm-up and a 10-minute cool-down. The core part of each training session consisted of a range of aerobic exercises, i.e. one day of the week on the treadmill, and the second one on the bike (BH Fitness equipment). The high-volume MICT group performed 45 minutes aerobic exercise, whereas the high-and low-volume HIIT groups performed 45 and 20 minutes, respectively. The intensity was individually tailored to each participant's HR at moderate (R2) or vigorous (R3) intensities, adjusting the speed and/or incline of the treadmill or the power and speed on the exercise bike. The rationale of mixing stationary exercise bike and treadmill was to avoid the osteoarticular impact of two treadmill days taking into account the nature of the HIIT programme and the impact derived from overweight/obese participants. The high-volume MICT group performed 45 minutes of continuous steady training at R2. Supervised exercise training protocols have previously been explained in full. 16 Considering the average _ VO 2peak at baseline for all participants (2.01 AE 0.5 L/min), the total work performed by the three exercise groups was calculated using the _ VO 2 -time relationship. As such, the moderate intensity at R2 was taken as 65% of _ VO 2peak (1.3 L/ min) and the high intensity at R3 as 90% of _ VO 2peak (1.8 L/min). Thus, the high-volume MICT group . A criterion for completing the study was set at 100%. Thus, all participants in the supervised exercise groups performed 32 sessions; if a session was missed (a maximum of four were allowed), these were added on to the end of the 16-week programme, maintaining the two sessions per week.
Diet intervention. A hypocaloric and controlled sodium diet (3-6 g/day) was prescribed for each participant. The diet was designed to provide 25% less energy than their daily energy expenditure and to achieve a weekly loss in body mass of between 0.5 and 1.0 kg in accordance with the recommendations of the American Diabetes Association and the Spanish Society for the Study of Obesity. 21 The diet contained approximately 30% fat, 15% protein and 55% carbohydrates and was designed in accordance with the DASH diet.
7 Every 2 weeks participants were weighed and received encouragement and advice alongside nutritional counselling in order to aid compliance.
Statistical analysis
Descriptive statistics were calculated for all variables. Data are expressed as mean AE standard deviations (SD) and the range. All variables that were not normally distributed using a Kolmogorov-Smirnov test were log transformed prior to any analysis. Analysis of variance was used to determine if there were significant preintervention between-group differences. The comparison of frequencies in categorical variables among groups was performed using the chi-square test. A two sample t-test was used to determine whether there was a significant difference in the recorded data between pre-and post-intervention within each group. Analysis of covariance was used to examine the delta (Á) score for each group (AC, high-volume MICT, high-volume HIIT, low-volume HIIT), adjusting for age, sex, changes in body mass and the initial value of each of the dependent variables. Helmert contrasts were performed to analyse the difference between the three exercise groups pooled together and the AC group. Bonferroni correction was used to determine the level of significance when a significant main effect was found. Data were analysed according to the intention-to-treat principle. Statistical significance was set at P < 0.05. All statistical analyses were performed with SPSS version 22.0. Power calculation was completed using the G*Power 3 analysis program. 22 The required sample size was determined for the primary outcome variable (SBP). It was identified that adequate power (0.80) to evaluate differences in our design consisting of four experimental groups would be achieved with 164 people (41 each group, a ¼ 0.05, effect size f ¼ 0.27) based on the pilot study with an SD of 9 mmHg.
Results
Baseline characteristics
Participants and medications were classified by groups and are presented in Table 1 . Baseline data for all 
Physiological changes
Following the 16-week intervention, resting SBP, DBP, mean BP and HR decreased (P < 0.05) ( Table 2) . Furthermore, in all groups, CRF expressed as _ VO 2peak (L/min) (AC, Á ¼ 10%; P < 0.05; high-volume MICT, Á ¼ 15%; high-volume HIIT, Á ¼ 25%; and lowvolume HIIT, Á ¼ 25%; P < 0.001), _ VO 2peak (mL/kg/ min) and metabolic equivalents of task (METs) (P < 0.001) increased. All groups increased at least one MET (Table 2 and Figure 2) . However, at VT1 and VT2 (mL/kg/min) improvements were observed in highvolume HIIT for VT1 (P ¼ 0.003) and both HIIT exercise groups for VT2 (high-volume HIIT, P < 0.001 and low-volume HIIT, P ¼ 0.016). In contrast, no significant changes were seen in the AC and high-volume MICT groups for either VT1 or VT2. Following Bonferroni correction, there were no significant between-group differences in any haemodynamic variables (i.e. BP and HR) ( Table 2 ). However, the AC group showed a smaller but significant improvement in _ VO 2peak (P < 0.001) compared with all exercise groups (high-volume MICT, mean difference 0.606, 95% confidence interval (CI) -2.193-3.405 mL/kg/min; high-volume HIIT, mean difference 3.215, 95% CI 0.418-6.012 mL/kg/min; and low-volume HIIT, mean difference 2.846, 95% CI 0.082-5.610 mL/kg/min) and METs (P < 0.001). Furthermore, both HIIT groups showed a greater (P ¼ 0.008) _ VO 2peak and MET (P ¼ 0.018) than the high-volume MICT group. In contrast, there were no significant between-group differences in any VT variables.
Anthropometric and body composition
Following 16 weeks intervention body mass, BMI, waist and hip circumferences, waist-to-hip ratio (WHR), and fat body mass (FBM) decreased (P < 0.05) in all groups (Table 2 ). In addition, fat-free mass (FFM) and the FFM/FBM ratio increased (P < 0.05). Following Bonferroni correction, there were significant between-group differences in anthropometric and body composition. The AC group had a smaller body mass reduction (T0 vs. T1 difference%, Á ¼ À6.6%; P ¼ 0.029) and change in BMI (Á ¼ 6.7%; P ¼ 0.030) compared with those in all exercise groups: high-volume MICT (Á ¼ À8.3%); high-volume HIIT (Á ¼ À9.7%); and low-volume HIIT (Á ¼ À6.9%). Furthermore, the high-volume HIIT group had a greater reduction in body mass (P ¼ 0.011, mean difference 2.436, 95% CI -4.972-0.099 kg) and BMI (P ¼ 0.015, mean difference 0.805, 95% CI -0.066-1.675 kg/m 2 ) compared with the low-volume HIIT group. However, there were no significant betweengroup differences observed for WHR. With respect to body composition, there were no significant differences in %FFM between the AC and all exercise groups (Á ¼ 4.0%; P ¼ 0.062): high-volume MICT (Á ¼ 6.2%); high-volume HIIT (Á ¼ 6.8%); and lowvolume HIIT (Á ¼ 4.6%). However, the %FFM gain in the high-volume HIIT group was greater than the AC group (P ¼ 0.039). Similarly, there were no significant differences in %FBM when exercise groups were compared together with the AC group (Á ¼ À8.1%; P ¼ 0.062): high-volume MICT (Á ¼ À11.3%); highvolume HIIT (Á ¼ À14.1%); and low-volume HIIT group (Á ¼ À9.6%). However, the high-volume HIIT group had a greater reduction of %FBM than the AC group (P ¼ 0.038).
Pharmacological therapy
Following the 16-week intervention, medication was reduced from 86.9% to 79.3%. Furthermore, 37.7% of participants who still took medication had their dose reduced. The percentage of participants who took one, two, three or more than four medications was also reduced to 35.4%, 29.9%, 8.5% and 5.4%, respectively. In particular, 32.3% of participants took ACEIs, 39 % ARBs, 30.5% diuretics, 15.2% calcium antagonists, 6.1% beta-blockers, 11.0% statins, 6.7% hypoglycaemic agents, 3.7% antiplatelets and 1.2% anticoagulants. The chi-square test revealed that there were no significant between-group differences in medication reduction.
Discussion
To our knowledge, this is the first known study to investigate the impact of exercise programmes, which use different intensities and volumes in conjunction with a dietary intervention in overweight/obese, sedentary adults diagnosed with hypertension. The main findings of the study were: (a) all groups significantly improved BP, CRF, body composition following 16 weeks intervention; (b) a substantial decrease of pharmacological treatment was observed; (c) hypocaloric diet and 2 days of supervised exercise showed improved body mass and CRF compared with a diet only intervention (AC group), but no significant between-group differences were observed in BP; (d) the high-volume HIIT exercise elicited a greater improvement in body mass and body composition than the low-volume HIIT exercise; and (e) the exercise-induced improvement in CRF is more dependent on intensity than volume. In this study, a 16-week lifestyle intervention significantly improved cardiovascular risk factors (i.e. BP, CRF and adiposity) in all groups, and pharmacological therapy was largely reduced or removed completely. Hence, the hypocaloric DASH diet along with both supervised aerobic exercise and no supervised physical activity recommendations could offer an optimal nonpharmacological tool in the management of hypertension. As such, this could result in a cost-effective model for cardiovascular disease prevention 8 and healthcare cost reduction. These results corroborate those of previous investigations that suggested overweight/ obese people with above normal BP could improve BP and body mass, vascular and autonomic function when they combine exercise and the DASH diet with calorie restriction.
9,24 Furthermore, we provide evidence that the combined effects of physical activity and hypocaloric diet enhance BP and reduce the need for pharmacological therapy. 25 To this end, contrary to our hypothesis, all supervised exercise groups had a reduced BP similar to the AC group post-intervention (7-9 mmHg in SBP and 3-5 mmHg in DBP). As such, the potential of the DASH diet to elicit significant improvements in SBP and DBP in individuals with hypertension who are overweight/obese is confirmed, 8 and it appears to be independent of the FITT principle. However, the lack of between-group differences in BP in the current study could in part be explained by: (a) the role physical activity plays in augmenting baroreflex dysfunction, which may result in a reduced sympathetic outflow with a lowered BP and HR response; 26, 27 (b) the different exercise interventions appear to be medication dependent with similar BP reduction following all exercise intensities (i.e. MICT or HIIT); 11 and (c) 2 days of supervised exercise may not be enough to differentiate between exercise modalities over the 16-week period. Previously, it has been reported that there is greater antihypertensive effect seen in response to high-intensity exercise when compared with lower exercise intensities. 11 Previous research found that HIIT three times a week elicited greater significant reductions in BP than MICT and a control group following a 12-week intervention. 12 However, it should be noted that participants using the antihypertensive drug in the mentioned study performed a wash-out before inclusion and so a greater effect may have been seen. To achieve a negative energy balance is to challenge and target specific pathways in order to produce beneficial changes in the pathogenesis of obesity-related hypertension. 2 In the present study, despite the antihypertensive medication and the metabolic potential side effects, 1,4 a dual treatment of hypocaloric diet combined with supervised exercise twice a week was the optimal way to reduce body mass compared with the AC group. More specifically, high-volume HIIT significantly enhanced body mass reduction (kg, #9.7%), and fat distribution the most (%FFM "6.8 and %FBM #14.1). Given that, high-volume MICT and lowvolume HIIT exercise programmes were performed with the same frequency but a reduced intensity and volume, respectively, the improvements seen in highvolume HIIT compared with the other two exercise programmes were likely to be caused by enhanced energy expenditure. These data suggest that sedentary people with overweight/obesity and hypertension can adapt and respond to exercise training during an energy-deficit programme with a dose-response curve related to volume and intensity. Furthermore, it has been shown that high levels of moderate to vigorous intensity physical activity are associated with longterm body mass loss maintenance, 28 despite the probable adaptive metabolic response caused by the compensatory downregulation in resting energy expenditure following exercise-induced body mass loss. 29 CRF is an independent predictor of all-cause and disease-specific mortality in various populations irrespective of BMI. 30 Thereby, the fat-but-fit paradigm has been given much attention with respect to reducing the risk of illness and death. 31, 32 Thus, in the present study (Table 1) , while all participants were overweight/ obese and considered unfit at baseline with CRF classified as poor (<24.4 mL/kg/min in men and <19 mL/ kg/min in women), 23, 33 following the 16-week intervention CRF was improved and classified as 'fair to good'. 33 Furthermore, all groups improved by at least 1 MET (Figure 2 ) during the course of the intervention. As such, although participants were still classified as overweight their CRF increased by 16-36%, which is associated with a considerable improvement in cardiovascular risk and reduced all-cause mortality. 34 In addition, the magnitude of change in CRF improvement was significantly different between exercise groups. In particular, both HIIT programmes elicited significantly greater improvements in CRF than the high-volume MICT and AC (Table 2 and Figure 2 ) groups. In addition, the HIIT groups showed significant improvements in submaximal variables such as VT (Table 2) . These enhanced improvements in CRF may be due to stress adaptations, which have previously been shown to cause notable cellular, vascular and metabolic adaptations during HIIT. 35 One remarkable finding of the present study was that HIIT improved CRF irrespective of the training volume (low vs. high volume). Our findings reinforce previous studies, which suggest lowvolume HIIT is a time-efficient and effective protocol in clinical populations answering the question 'Can less be more'? 36, 37 As such, it may be that low-volume HIIT is more appealing for individuals who do not have enough time to train for long periods, or for those who have medical conditions which prevent them from performing exercise for prolonged periods of time. 13, 35 However, taking into account the urgent need of increasing caloric expenditure and CRF in this population, low-volume HIIT could be an option to tailor supervised exercise along with daily recommendations of lower-intensity physical activities. 38 Although the current study has provided clear evidence for the benefits of combining a hypocaloric DASH diet with exercise, there are some limitations which should be considered: (a) although every effort was made to manage unsupervised time, physical activity performed by participants in the AC group could not be controlled, and (b) it is difficult to regulate and monitor the adherence of participants to the diet.
Conclusions
In summary, the present study has shown that the combination of the hypocaloric DASH diet with different supervised aerobic exercise programmes twice a week offers an optimal non-pharmacological tool in the management of risk factors in sedentary individuals with overweight/obesity and hypertension. Benefits include an enhanced control of BP, body mass composition, CRF and pharmacological treatment. A dose-response curve related to volume and intensity in the form of 2-weekly bouts of high-volume HIIT provided significantly greater reductions in body mass compared with low-volume HIIT. However, the key to enhancing CRF in this population appears to be linked with exercise intensity irrespective of duration. As such, lowvolume HIIT may be a time-efficient and effective method of improving health.
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